A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agent (Q70019792)
Jump to navigation
Jump to search
scientific article published on 01 September 1986
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agent |
scientific article published on 01 September 1986 |
Statements
A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation. Special Programme of Research, Development and Research Training in Human Reproduction (English)
S Said
K Omar
S Koetsawang
O Kiriwat
Y Srisatayapan
A Kazi
F Ajmal
H H Wynter
A Pretnar-Darovec
1 September 1986